Overview

Cocrystal Pharma’s Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against the Emerging GII.17 Variants

Read Press Release

Latest Financial Results

Stock Information

Nasdaq:

COCP

Price

Loading...

Change

Loading...

Mkt Cap

Loading...

Volume

Loading...
52 week Low/High Loading...
Day Low/High Loading...